- Home
- AARD vs GPRO Comparison
AARD vs GPRO Comparison
Compare AARD & GPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AARD
- GPRO
- Stock Information
- Founded
- AARD 2017
- GPRO 2004
- Country
- AARD United States
- GPRO United States
- Employees
- AARD N/A
- GPRO N/A
- Industry
- AARD Biotechnology: Pharmaceutical Preparations
- GPRO Industrial Machinery/Components
- Sector
- AARD Health Care
- GPRO Consumer Discretionary
- Exchange
- AARD Nasdaq
- GPRO Nasdaq
- Market Cap
- AARD 242.9M
- GPRO 194.6M
- IPO Year
- AARD 2025
- GPRO 2014
- Fundamental
- Price
- AARD $8.59
- GPRO $1.49
- Analyst Decision
- AARD Strong Buy
- GPRO
- Analyst Count
- AARD 5
- GPRO 0
- Target Price
- AARD $32.60
- GPRO N/A
- AVG Volume (30 Days)
- AARD 77.3K
- GPRO 8.9M
- Earning Date
- AARD 08-13-2025
- GPRO 08-11-2025
- Dividend Yield
- AARD N/A
- GPRO N/A
- EPS Growth
- AARD N/A
- GPRO N/A
- EPS
- AARD N/A
- GPRO N/A
- Revenue
- AARD N/A
- GPRO $746,731,000.00
- Revenue This Year
- AARD N/A
- GPRO N/A
- Revenue Next Year
- AARD N/A
- GPRO $9.72
- P/E Ratio
- AARD N/A
- GPRO N/A
- Revenue Growth
- AARD N/A
- GPRO N/A
- 52 Week Low
- AARD $4.88
- GPRO $0.40
- 52 Week High
- AARD $19.58
- GPRO $2.37
- Technical
- Relative Strength Index (RSI)
- AARD N/A
- GPRO 55.28
- Support Level
- AARD N/A
- GPRO $1.18
- Resistance Level
- AARD N/A
- GPRO $1.88
- Average True Range (ATR)
- AARD 0.00
- GPRO 0.16
- MACD
- AARD 0.00
- GPRO 0.01
- Stochastic Oscillator
- AARD 0.00
- GPRO 44.29
About AARD Aardvark Therapeutics Inc. Common Stock
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About GPRO GoPro Inc.
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.